CFTR polymorphisms in patients with alcoholic chronic pancreatitis

Pancreatology

Volumn 9, Issue 1-2, 2009, Pages 173-181

  Da Costa, Marianges Zadrozny Gouvêa ^a   Guarita, Dulce Reis ^a   Ono Nita, Suzane Kioko ^a   Nogueira, Jerônimo De Alencar ^a   Nita, Marcelo Eidi ^a   Paranaguá Vezozzo, Denise Cerqueira ^a   De Souza, Marcelo Tavares ^a   Do Carmo, Eliane Pereira ^a   Teixeira, Ana Cristina De Sá ^a   Carrilho, Flair José ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alcoholism; Cystic fibrosis transmembrane conductance regulator; Pancreatitis genetics; Polymorphisms

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; AGED; ALCOHOLISM; ARTICLE; CASE CONTROL STUDY; CFTR GENE; CHRONIC PANCREATITIS; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 57449083863     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000178889     Document Type: Article

References (40)

1. Marques ACPR, Ribeiro M: Projeto Diretrizes. Associação Médica Brasileira e Conselho Federal de Medicina, 2002, pp 1-20.
2. Witt H: Chronic pancreatitis and cystic fibrosis. Gut 2003; 52: 1-25.
3. Buscail L: New insights in idiopathic pancreatitis. Gastroenterol Clin Biol 2003; 27: 391- 393.
4. Mott CB, Guarita DR: Pancreatite Crônica; in Cordeiro F (eds): Condutas em Gastroenterologia. São Paulo, Livraria e Editora Revinter Ltda, 2004, pp 632-634.
5. Burton PR, Tobin MD, Hopper JL: Key concepts in genetic epidemiology. Lancet 2005; 366: 941-951.
6. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339: 645-652.
7. Haber PS, Norris MD, Apte MV, Rodgers SC, Norton ID, Pirola RC, Roberts-Thomson IC, Wilson JS: Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis gene. Alcohol Clin Exp Res 1999; 23: 509-512.
8. Monaghan KG, Jackson CE, Kukuruga DL, Feldman GL: Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol related pancreatitis. Am J Med Genet 2000; 94: 120-124.
9. Kimura S, Okabayashi Y, Inushima K, Yutsudo Y, Kasuga M: Polymorphism of cystic fibrosis gene in Japanese patients with chronic pancreatitis. Dig Dis Sci 2000; 45: 2007- 2012.
10. Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX: Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. Gut 2001; 48: 70- 74.
11. Gaia E, Salacone P, Gallo M, Promis GG, Brusco ABC, Carlo A: Germline mutations in CFTR and PSTI genes in chronic pancreatitis patients. Dig Dis Sci 2002; 47: 2416- 2421.
12. Bernardino AL, Guarita DR, Mott CB, Pedroso MRA, Machado MCC, Laudanna AA, Tani CM, Almeida FL, Zatz M: CFTR, PRSS1 and SPINK1 in the development of pancreatitis in Brazilian patients. J Pancreas 2003; 4: 169-177.
13. Pezzilli R, Morselli-Labate AM, Mantovani V, Romboli E, Selva P, Migliori M, Corinaldesi R, Gullo L: Mutations of the CFTR gene in pancreatic disease. Pancreas 2003; 27: 332-336.
14. Perri F, Piepoli A, Stanziale P, Merla A, Zelante L, Andriulli A: Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis. Eur J Hum Genet 2003; 11: 687-692.
15. Casals T, Aparisi L, Costa CM, Gimenez J, Ramos MD, Mora J, Diaz J, Boadas J, Estivill X, Farré A: Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 2004; 28: 374-379.
16. Fujiki K, Ishiguro H, Ko SBH, Mizuno N, Suzuki Y, Takemura T, Yamamoto A, Yoshikawa T, Kitagawa M, Hayakawa T, Sakai Y, Takayama T, Saito M, Kondo T, Naruse S: Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. J Med Genet 2004; 41:e55.
17. Nakamura Y, Ohmori T, Higuchi S, Maruyama K: Certain background factors exhibit an association with an increased risk for pancreatic calcification among Japanese male alcoholics. Pancreas 2005; 31: 225-231.
18. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996; 14: 141-145.
19. Howes N, Greenhalf W, Stocken DD, Neoptolemos JP: Cationic trypsinogen mutations and pancreatitis. Clin Lab Med 2005; 25: 39- 59.
20. Teich N, Mossner J: Genetic aspects of chronic pancreatitis. Med Sci Monit 2004; 10: RA325-RA328.
21. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25: 213-216.
22. Witt H, Luck W, Becker M, Böhmig M, Kage A, Truninger K, Ammann RW, O'Reilly D, Kingsnorth A, Schulz HU, Halangk W, Kielstein V, Knoefel WT, Teich N, Keim V: Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis. JAMA 2001; 285: 2716-2717.
23. Lempinen M, Paju A, Kemppainen E, Smura T, Kylanpaa ML, Nevanlinna H, Stenman J, Stenman UH: Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland. Scand J Gastroenterol 2005; 40: 225-230.
24. Tukiainen E, Kylanpaa ML, Kemppainen E, Nevanlinna H, Paju A, Repo H, Stenman UH, Puolakkainen P: Pancreatic secretory trypsin inhibitor (SPINK1) gene mutations in patients with acute pancreatitis. Pancreas 2005; 30: 239-242.
25. Kume K, Masamune A, Mizutamari H, Kaneko K, Kikuta K, Satoh M, Satoh K, Kimura K, Suzuki N, Nagasaki Y, et al: Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis. Pancreatology 2005; 5: 354-360.
26. Lee KH, Ryu JK, Yoon WJ, Lee JK, Kim YT, Yoon YB: Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis. Dig Dis Sci 2005; 50: 1852-1856.
27. Cohn JA, Mitchell RM, Jowell PS: The role of cystic fibrosis gene mutations in determining susceptibility to chronic pancreatitis. Gastroenterol Clin N Am 2004; 33: 817-821.
28. Lyon E, Miller C: Current challenges in cystic fibrosis screening. Arch Pathol Lab Med 2003; 127: 1133-1139.
29. Bruno MJ: Current insights into the pathogenesis of acute and chronic pancreatitis. Scand J Gastroenterol 2001; 36(suppl 234): 103-108.
30. Whitcomb DC: Value of genetic testing in the management of pancreatitis. Gut 2004; 53: 1710-1717.
31. Cichoz-Lach H, Partycka J, Nesina I, Celinski K, Slomka M, Wojcierowski J: Genetic polymorphism of alcohol dehydrogenase 3 in alcohol liver cirrhosis and in alcohol chronic pancreatitis. Alcohol Alcohol 2006; 41: 14-17.
32. Verlaan M, te Morsche RH, Roelofs HM, Laheij RJ, Jansen JB, Peters WH, Drenth JP: Glutathione S-transferase Mu null genotype affords protection against alcohol induced chronic pancreatitis. Am J Med Genet 2003; 120A:34-39.
33. Ockenga J, Vogel A, Teich N, Keim V, Manns MP, Strassburg CP: UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 2003; 124: 1802-1808.
34. Bendicho MT, Guedes JC, Silva NN, Santana GO, dos Santos RR, Lyra AC, Lyra LG, Meyer R, Lemaire DC: Polymorphism of cytokine genes (TGF-beta1, IFN-gamma, IL-6, IL-10, and TNF-alpha) in patients with chronic pancreatitis. Pancreas 2005; 30: 333- 336.
35. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M, et al: Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 1998; 101: 487-496.
36. Nakamura Y, Ohmori T, Ishikawa A, Kobayashi Y, Imazeki H, Higuchi S, Maruyama K: Homozygous (TG)11 allele in intron 8 of the cystic fibrosis transmenbrane conductance regulator (CFTR) gene has a protective role against bicarbonate decrease in pure pancreatic juice among Japanese male alcoholics. Intern Med 2004; 43: 1131-1137.
37. Ammann RW: Diagnosis and management of chronic pancreatitis: current knowledge. Seiss Med Wkly 2006; 136: 166-174.
38. Hill AB: The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295.
39. Vantyghem MC, Moussaïd-Guennoun R, Perimenis P, Marcelli-Tourvieille S, Perez T, Wallaert B: Cystic fibrosis diabetes in adult. Ann Endocrinol (Paris) 2005; 66: 347-354.
40. Gaia E, Salacone P, Salmin P, Brusco A, Bacillo E, Arduino C: Differences in clinical manifestations in patients with chronic pancreatitis and mutations of CFTR, SPINK1 e PRSS1 genes. J Pancreas 2004; 6: 521.